KVUE - Kenvue Inc.
Health CarePrice History
About
Company Overview
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Price
$17.24
52-Week Range
Dividend Yield
4.81%
Dividend Score
C
Dividend
Valuation
Profitability
Financial Health
Cash Flow
Analyst Consensus
12 analysts
Dividend Growth
Most Recent Annual Growth
1.98%
3-Year Avg Growth
N/A
5-Year Avg Growth
N/A
Annual Dividends
Year-over-Year Growth
Recent Dividend History
| Ex-Dividend Date | Amount |
|---|---|
| Feb 11, 2026 | $0.2080 |
| Nov 12, 2025 | $0.2080 |
| Aug 13, 2025 | $0.2080 |
| May 14, 2025 | $0.2050 |
| Feb 12, 2025 | $0.2050 |
| Nov 13, 2024 | $0.2050 |
| Aug 14, 2024 | $0.2050 |
| May 07, 2024 | $0.2000 |
| Feb 13, 2024 | $0.2000 |
| Nov 07, 2023 | $0.2000 |
| Aug 25, 2023 | $0.2000 |